Organizations, support & community

Detailed differential and testing discussion for use with a clinician; not a home testing protocol.

Overview of anatomy and causes to discuss with clinicians; not an emergency decision tool or self-treatment guide.

Detailed pathway and differential information for discussion with a clinician, not self-localization or a home drop test.

Detailed discussion of implant types, support and surgical options. Technical education, not a personalized surgical recommendation.

Detailed ophthalmic overview with references; technical material is not a personalized management plan.

Detailed phenotype, imaging and management reference. Specialist assessment is needed for individual treatment choices.

Anatomy and differential diagnosis to discuss with a specialist. Some treatment summaries rely on older references and are not a self-treatment algorithm.

Explains the broader eye syndromes and differential; not an active support group or personal cancer screening plan.

Mechanism, differential and treatment-planning context for clinician discussion.

Detailed anatomy and differential diagnosis; specialist-oriented education rather than a personal diagnostic service.

Explains the key optic-nerve distinction between neighboring anatomical syndromes; not a triage checklist.

Anatomy, signs, investigation and treatment controversy; technical material does not replace urgent trauma assessment.

Detailed guidance useful for specialist discussions about symptoms, scans and intervention.

Current patient overview of the linked corneal and pressure problems.

Current patient explanation of herpes simplex eye disease and clinician-directed care.

Professional patient education on concerning photo signs; not an invitation to self-diagnose.

Official association website with a pediatric ophthalmologist directory and patient resources; a listing does not guarantee access.

Accessible background and official pediatric clinician-directory links.

Family explanations of causes, treatments and practical questions for pediatric eye care.

Child-focused explanation and official clinician-directory links.

Accessible child-focused explanation and official clinician-directory route.

Explains when genetic eye evaluation may be appropriate, including congenital or juvenile glaucoma. This is education and specialist discovery, not an ARS treatment service.

Explains adult alignment problems and links to a specialist directory; local referral and coverage requirements vary.

Accessible explanation and links to the society’s clinician directory.

Child-focused explanation, including large/persistent lesions and anesthesia considerations.

Useful explanation of testing and symptom variability. Comparative treatment claims should be read alongside the trials summarized here.

Explains adult alignment care and links to specialist discovery, including functional reasons for treatment.

Current plain-language explanation of adult inward eye turns and why their causes differ.

Explains alignment care and links to clinicians; access, referral and insurance vary.

Explains adult eye alignment and links to specialist discovery; not every diplopia problem is strabismus.

Accessible explanation and official clinician-directory link.

Explains congenital and acquired patterns and why some children show head tilt without reporting double vision.

Child-focused causes and examination information with official clinician-directory routes.

Accessible childhood and acquired-nystagmus information with links to the professional society.

Explains early-onset and acquired patterns, assessment and selected treatment goals; specialist access varies.

Pediatric eye explanation with links to related conditions and specialist resources.

Parent-oriented explanation of anatomy, symptoms and hospital care.

Explains why a white reflex needs evaluation and is not one diagnosis.

Childhood visual-development and treatment explanation, with official clinician-directory links.

Explains adult alignment care and links to specialist discovery; local access and coverage vary.

Current explanation of adult inward eye deviation, including different underlying causes.

Explains movement, childhood development and the limits of symptomatic prism or patch approaches.

Adult causes, treatment questions and specialist-directory routes.

Explains congenital and acquired palsy, childhood vision development and the limits of alignment and eyelid surgery.

Condition-specific explanation of imaging and the distinction from neovascular AMD.

Retina-specialist explanation of symptoms, history and diagnostic imaging.

Condition-specific explanation with large-print and translated factsheet links.

Patient explanation of nevi, imaging and the distinction between benign lesions and complications.

Retina-specialist patient information explaining retinal findings and treatment categories.

Explains routes, investigation and treatment, with a large-print version and a retina-specialist directory linked from the page.

Condition information, large-print and translated versions, with links to a retina-specialist directory.

Condition-specific clinical background, testing and care context.

Overview with large-print information and linked retina-specialist resources.

Condition-specific explanation of symptoms, examination and repair options, with large-print and Spanish versions linked.

Specific explanation of the silent finding, monitoring and retinal-detachment warning signs, with a downloadable factsheet.

Retinal-specialist education and links to a specialist directory; not an individual surgical recommendation.

Condition-specific information to discuss with the treating team.

Focused patient explanation and retinal-specialist education; treatment intervals require an individual plan.

Focused retinal-specialist explanation of scars, symptoms and neovascular treatment.

Condition-specific explanation of fragments, medical care and vitrectomy, with linked large-print and translated material. Generic risk figures should not be treated as personal surgical estimates.

Accessible explanation of central and branch arterial occlusion and retinal examination; not an emergency contact service.

Explains the tear–detachment relationship and clinician-directed treatment.

Explains central occlusion, swelling and neovascular risks; links to specialist resources.

Separate explanation of branch disease and its assessment and treatment.

Focused explanation of silent disease, vascular stages and treatment options.

Retinal-specialist explanation of light injury and prevention, with the society’s broader physician information.

Retina-specialist overview of eye examination, imaging and referral to ocular oncology. Treatment specifics should be checked against the current oncology plan.

Patient explanation of the vitreous–macula interface, imaging and management questions; verify injection availability against current local sources.

Defines vitreous and hemorrhage terminology, with links to retinal conditions.

Patient explanation of retinal splitting, childhood symptoms and complications.

Migraine-specific context; relevant when migraine contributes, not a diagnosis for every light-sensitive person.

Organization-owned route to national aniridia associations and community contacts. Use its country links to find relevant language and local eligibility; peer connection does not supply individual treatment advice.

Functional-vision, learning-media and mobility information, with a route to FamilyConnect. Peer connection is support rather than clinical advice. US-focused service discovery is broader than ONH; local eligibility and contact arrangements vary.

Family, school and rehabilitation resources for blindness and low vision.

Practical resources and service directory for visual disability. Useful if function remains affected after injury; not a rare-syndrome-specific clinic or emergency service.

Useful vision-rehabilitation information when the underlying cause is stroke or acquired brain injury.

Useful when INO follows stroke or brain injury; describes orthoptic assessment and practical support.

Explains assessment and practical vision support after stroke or acquired brain injury.

Practical visual assessment and adaptation information when the underlying cause is stroke or brain injury.

Useful when a brain injury or stroke is the cause; separates eye-movement, visual-field and perceptual problems rather than treating them as one symptom.

Moderated broader cancer community for patients and carers. Not an optic-infiltration-specific group or medical emergency service.

Moderated support for people affected by cancer and carers. Broader than paraneoplastic optic neuropathy; not an antibody interpretation or emergency service.

Organization describes a fully moderated forum for people affected by cancer and their carers. Broader than radiation optic neuropathy; peer discussion is not diagnosis or emergency care, and participation may require an external account.

Supports ministries and local teams with SAFE implementation, educational material and research; not a global direct-to-patient clinic.

General disease context and distinction from variant CJD.

Current US preventive-vaccination recommendations, including prior shingles and immune-compromised populations. Discuss personal timing with the treating clinicians.

Explains immediate ophthalmic collaboration and why ocular disease needs a dedicated medical pathway.

Practical prevention, lens hygiene and backup-glasses guidance.

Current infection and testing information, including the distinction between usual cat-scratch disease and disseminated ocular disease; written for health professionals.

Diagnostic and management framework to discuss with a clinician, including when CSF testing is indicated; not a self-prescribing resource.

Explains treatment goals and the need to assess co-infection before taking medicine.

Condition-specific information to discuss with the treating team.

Explicitly distinguishes presumed ocular scars from rare active disseminated eye infection and explains why antifungals are not routine POHS care.

Condition-specific information to discuss with the treating team.

Patient explanation of the sign and underlying investigation; a starting point for understanding a referral, not a personal assessment.

Multidisciplinary program information and formal appointment routes, not an endorsement of a specific outcome.

Explains older treatment evidence and its uncertainty; this is an evidence charity, not a symptom helpline or prescribing service.

Plain-language review of controlled evidence and its limitations, rather than personal treatment selection.

Evidence summary for seasonal/perennial allergy; not an individual prescribing service or patient forum.

Explains the limited randomized evidence for early surgery; not a decision tool for delaying urgent care.

Plain-language comparison of two DCR approaches and the uncertainty of direct trial evidence.

Explains the small randomized evidence base and why its findings need to be interpreted in the correct severity group.

Explains comparative-evidence gaps for painful recurrent surface breakdown.

Plain-language explanation of what comparative treatment studies do and do not establish; not an individual treatment plan.

Evidence limitations in nonpharmacological treatment studies.

Explains controlled graft comparisons and evidence gaps rather than recommending a personal operation.

Plain-language comparison of research and evidence gaps, not individual treatment selection.

Treatment-evidence summary to read alongside later trials.

Accessible patient summary and current update notes; additional professional material requires sign-in.

Current emphasis on immediate irrigation and same-day specialist assessment; full professional guidance may require sign-in.

Accessible overview and current referral considerations; full professional guidance is behind sign-in.

January 2026 public summary explains anterior versus posterior disease and urgent referral. The detailed professional section requires a login.

Technical classification reference for the distinction between endothelial and other corneal dystrophies.

Fuchs-focused webinars and the Fuchs’ Friends private peer community, also open to other corneal dystrophies. Application and personal information are required; shared experience and patient-recommended specialists are not comparative clinical evidence.

Ocular melanoma education, specialist-center information and research resources. Its treatment-center list is a starting point, not a quality ranking or endorsement.

Condition-specific diabetes eye information and routes to broader diabetes support. Relevant to diabetic retinopathy, not every vitreous bleed.

Practical navigation, a helpline, discussion forums and scheduled groups for ocular-surface disease. Peer experiences are non-medical; commercial products and individual stories do not establish treatment effectiveness.

Relevant when ocular-surface disease is contributing to watering. It does not assess tear-duct obstruction or replace an eye examination.

Useful when associated chronic surface symptoms cause distress: education, practical support and peer meetings. No dedicated marginal-keratitis group is claimed.

Broader practical and emotional support for persistent ocular-surface problems, not an emergency infection service or dedicated organism-specific group.

Broader practical and emotional support for persistent surface symptoms; not a dedicated HSV treatment group or urgent-care service.

Detailed case, imaging and differential discussion. A severe selected case is not a typical personal prognosis or proof of treatment effectiveness.

A real clinical retinal-image example with attribution and a stated image license. The photograph is a view of the retina, not a recording of the person’s vision.

Best disease education with broader retinal-disease chapter events, resources and community connections. This is not a Best-only group; local availability varies, and early research news does not establish personal eligibility or treatment benefit.

Condition-specific research education, genetic-testing information and low-vision resource links. Program eligibility and trial recruitment must be checked individually.

Research explanations and inherited-retinal community information. Registry or study participation is optional and involves the external organization’s own privacy process.

Research updates and community information. Confirm a specific study’s current recruitment and eligibility with its official study site, rather than assuming a news item offers access.

Inherited-retinal research information, community resources and optional research-participation routes. A study listing does not guarantee recruitment or eligibility.

Detailed diagnostic pitfalls and management discussion; expert synthesis is not individualized prescribing advice.

Detailed discussion for use with the care team, with explicit evidence gaps.

Childhood-glaucoma booklet, family stories, helpline and community routes. Broader glaucoma support is relevant when ARS causes glaucoma; it is not a dedicated ARS charity.

Glaucoma information, helpline and peer support when the detachment occurs in a glaucoma-care journey; not an acute surgical service.

Helpline, education, buddy support and group information for the glaucoma component of ICE. Not a dedicated ICE diagnostic service.

Official academic reference to the 2024 adult guideline.

Broader rehabilitation, everyday-life and family support after acquired brain injury; not a dedicated rare-syndrome clinic.

Broader acquired-brain-injury support for everyday life and caregivers, not a dedicated Anton clinic.

Practical rehabilitation, daily life and family support after acquired injury.

Broader daily-life and rehabilitation support when acquired brain injury is the cause.

Broader rehabilitation and family support when acquired brain injury contributes, not a dedicated rare-perception clinic.

Recovery, daily-life, family and community support routes.

Patient-level explanation of diagnosis, treatment and recovery, including the need for urgent care for neurological changes.

Resources for children, adults, families and transition to adult care. Community networks include local and virtual routes; confirm age eligibility and current arrangements. Peer support is not shunt assessment.

Public educational videos and caregiver material, including diagnostic uncertainty and treatment conversations. External apps and accounts are optional and separate from VisualSim.

The URL contains a historical neighboring-condition name, but its current title and body are the official THS criteria. It is a professional reference, not a patient forum.

Official classification with distinctions and qualifying comments; not a home diagnostic score.

Explains inherited vitelliform disease and adult-onset terminology; its Best-disease focus does not establish that an acquired lesion is inherited.

Practical macular-disease information and support navigation; ask about eligibility for individual services.

Macular-disease support navigation and practical central-vision information; individual service eligibility varies.

Explains retinal complications and provides practical macular-disease support navigation.

Macular-disease support navigation and practical information for affected people and families.

CBS information, a support service and counselling or peer-support navigation. Its CBS counselling eligibility extends beyond macular disease; check current age, location and referral conditions on the host site.

Condition information with routes to a helpline, practical support and broader macular peer connection.

Explanation of causes plus routes to advice, local peer groups and help with central-vision tasks.

Condition information, advice routes, peer groups and practical help with central-vision tasks.

Condition explanation and practical, counseling and peer-support routes. Check current treatment information against the regulator and specialist.

Condition information, central-vision adaptations, advice and peer-support routes.

Advice, counseling and peer support for central-vision difficulties; not a PCV-specific treatment authority.

Broader central-vision support, counseling and peer connections. No dedicated POHS clinic or international POHS group is claimed.

Condition information plus advice, counseling and peer-support routes.

Broader support for persistent central sight loss, including peer groups and advice about daily tasks; not a dedicated light-injury clinic.

Condition-specific information, a helpline and an officially listed virtual Sorsby peer-support group, alongside broader macular support. Check current meeting arrangements with the charity; peer support is not medical advice. Historical vitamin A research on the information page is not a self-treatment recommendation.

Condition guide plus support for school, work, emotional adjustment and central sight loss; local service eligibility differs outside the UK.

Broader macular helpline, practical advice and local peer support for central visual difficulty. Not a VMT-only treatment service.

Concise explanation of symptoms, investigations and treatment; urgent illness still requires direct medical care.

Condition-specific clinical background, testing and care context.

Accessible introduction. Some subtype and gene listings are older than the specialist reviews.

Accessible overview of silent disease, symptoms and the importance of blood-pressure management.

Accessible background with links to specialist references; not individual surveillance advice.

Accessible introduction to the classic syndrome; individual findings and broader spectrum classification still require assessment.

Condition-specific information to discuss with the treating team.

Accessible background; older genetic candidate statements require interpretation alongside newer phenotype/genetics evidence.

Accessible introduction to phenotype and genetic diversity, for discussion with the care team.

Organization-owned directory for finding regional Moebius and facial-difference support. Listing is not proof of current local service capacity.

Explains minimum clinical criteria and multidisciplinary assessment rather than diagnosis by photographs.

Describes alignment and eye-movement assessment; access to the clinical service depends on local pathways.

Specialist-hospital overview of symptoms and the diagnostic/treatment context.

Assessment of alignment, binocular function and childhood vision needs; not guaranteed specialist access for every region.

Hospital patient information; local care access is distinct from reading the public page.

Explains blocked glands and when a specialist procedure may be considered.

Patient overview with links to biopsy and treatment information; public reading is distinct from access to a specialist service.

Describes assessment of focusing, binocular vision and movements; local referral pathways apply.

Information on professional binocular-vision and eye-movement assessment; local referral requirements apply.

Information about measuring and managing binocular and eye-movement problems; local referral pathways apply.

Describes professional assessment of binocular vision and eye movements; local access pathways apply.

Information about childhood visual development and alignment assessment.

Clear postoperative warning symptoms and immediate assessment advice. Use your own treating service’s emergency pathway where available.

Explains the drainage pathway, common causes and eyelid contributors.

A short explanation of the affected tissue, irritation and recurrence.

Explains pump-cell failure, symptoms and the interaction with cataract surgery.

Condition-specific patient explanation of eye involvement, treatment and recurrence; use local urgent-care routes outside its service area.

Overview with linked adult and pediatric CXL aftercare; the instructions for your own procedure take priority.

Plain-language explanation, lid-care demonstration and clear reasons to seek reassessment.

Explains urgent care, treatment intensity and follow-up.

Detailed disease information with counseling and liaison routes for hospital patients; access to services is local.

Specific information on an irregular-cornea cause of ghosting and its assessment; not every ghost image is keratoconus.

Information about assessment of double vision and alignment. Access to treatment depends on referral and service arrangements.

Practical explanation and instructions to seek review for worsening symptoms. Local emergency access differs elsewhere.

Describes assessment and management of eye coordination; clinical access follows local referral pathways.

Explains assessment of eye coordination and task-related complaints; it is not an international remote diagnosis service.

Describes orthoptic evaluation of alignment and visual tasks. Access to this hospital’s service requires its referral pathway.

Explains a specialist emergency service that assesses hemorrhage and retinal problems. The clinic is referral-only, not a walk-in or global emergency contact.

Relevant when the eye-movement problem is associated with multiple sclerosis. Information and organization-linked peer forum; forum experiences are not medical advice and INO does not by itself diagnose MS.

Symptom explanations, practical sight support and helpline/community routes. Local service availability needs checking.

Relevant only when neuroblastoma is suspected or diagnosed. Includes the tumour-associated OMAS trial; it is not a general explanation for all ocular flutter.

Detailed family treatment overview for discussion with the oncology team.

Plain-language anatomy, staging and treatment explanations to prepare for specialist discussion.

Patient information and publicly funded vision-research education. This is an educational resource, not a personal diagnosis or a patient support group.

Condition-specific information to discuss with the treating team.

Background on focusing errors and professional correction.

Accessible overview explaining that diagnosis depends on the clinical pattern rather than a single test.

Condition-specific clinical background, testing and care context.

Accessible explanation of causes, examination and treatment categories.

Accessible explanation of symptoms, diagnosis and care options.

Information on vision rehabilitation, accessible devices and task adaptations; ask locally about referral and service availability.

Plain-language clinical introduction and links to research; the NEI does not diagnose individual cases or provide physician referrals.

Accessible distinctions among causes and guidance on seeking assessment.

Plain-language symptoms, examination and links to research; NEI does not provide individual diagnosis or prescriptions.

Accessible overview of symptoms, assessment and broad treatment categories; not an individual care service.

Overview of symptoms, examination, OCT and why many mild cases are monitored.

Accessible explanation of corneal layers and broad disease categories.

Broader help with assistive technology, daily activities, employment and emotional support when lasting visual difficulty affects function. Not a zoster-specific treatment program.

Contains an accessible ICE section explaining iris changes, corneal swelling and glaucoma.

Explains urgent warning symptoms and the difference between a retinal break and detachment.

Accessible overview of testing and treatment categories, with links to the underlying conditions.

Explains focusing errors, examination and correction; does not provide individual prescriptions.

Explains the original prevention trial; historical 1998 evidence, not a current individualized dosing plan.

Explains vision rehabilitation, reading and device adaptations for persistent task difficulties. Local services require a separate referral or access check.

Patient explanation of central symptoms, testing and low-vision support. Read alongside the CDC distinction from active infection.

Useful when a dystrophy is suspected or diagnosed, rather than assuming every erosion is inherited.

Accessible focusing-error types, examination and treatment information.

Accessible warning symptoms, types, testing and treatment explanation.

Plain-language intraocular-inflammation guide explaining symptoms, assessment and treatment monitoring. It is broader than retinal vasculitis and does not provide a personal diagnosis or physician referral.

Practical description of assistive technology, daily living and mobility support, with directories for locating services. Eligibility and coverage depend on the local provider; the page does not itself deliver care.

Accessible disease explanation, low-vision links and information about NEI evaluation and research; US study access is eligibility-dependent.

Plain-language overview of anatomical forms, possible causes, assessment and treatment.

One important cause of leukocoria; the symptom is not itself a cancer diagnosis.

Evidence-based B12 diagnosis and management guidance; not a universal guide to all micronutrient optic neuropathies.

Official withdrawal notice helps explain why older treatment pages may list a medicine no longer marketed in the UK.

Detailed clinical and inheritance context, including syndromic distinctions.

Updated genetic and surveillance context for discussion with eye and genetics teams.

Condition-specific clinical background, testing and care context.

Detailed phenotype, genetic counseling and management discussion for use with a specialist.

Detailed molecular, clinical and family-counseling reference; updated in 2020, so ask specialists about subsequent developments.

Detailed genetic and management information, last updated in 2019. Use with current specialist advice and newer deletion literature.

Detailed isolated-versus-syndromic and counseling information to discuss with the care team.

Current 2026 genetic and management synthesis to discuss with the team.

Detailed KSS-spectrum, molecular and multidisciplinary-care information for specialist discussion.

Detailed genotype, diagnostic and counseling resource. It explicitly identifies areas where surveillance recommendations reflect expert experience rather than trial evidence.

Detailed genetics and clinical context; treatment sections should be read with the newer consensus.

Relevant when Joubert syndrome is being investigated or diagnosed; it is not proof that OMA implies that syndrome.

Detailed clinical, genetic and care information for discussion with clinicians.

Clinical reference to support questions for the treating team.

Current 2026 differential and management discussion; technical educational resource, not a home treatment protocol.

Updated 2025 molecular and multisystem information for discussion with genetics, kidney and eye teams.

Molecular and family-risk context; not an individual genetic interpretation.

Detailed, updated clinical genetics reference and resource links; useful for preparing questions with the inherited-retinal and hearing team.

Detailed genetic and clinical explanation for a selected possible cause, not a diagnosis for everyone with downbeat nystagmus.

Clinical genetics, differential diagnosis and family support reference. Its 2020 trial-recruitment statements are historical and should not be used as current recruitment information.

Practical information after temporary prism is prescribed.

Practical leaflet for professionally prescribed temporary prism.

Practical support after prescription of temporary prism, not a self-prescription tool.

Practical information for people prescribed temporary prisms. Suitability and driving advice require the treating team.

Practical information for people prescribed a temporary prism; not a way to choose prism strength independently.

Practical information for a prescribed temporary prism, with suitability determined by an orthoptist.

Official cost-help information for eligible sight tests and correction; not universal free care.

Helps distinguish symptom patterns and identifies situations requiring urgent assessment.

Practical patient information and clear distinctions between routine persistent symptoms and changes needing urgent advice.

Patient information, precautions and signs that warrant urgent advice.

Condition-specific information to discuss with the treating team.

Patient explanation, hygiene advice and return precautions for a red eye.

Information about symptom distinctions and urgent warning signs.

Public symptom and urgent-care information.

Practical advice on when routine or urgent assessment is appropriate.

Helps distinguish routine review from warning symptoms. It is not a diagnostic photograph comparison.

Immediate warning signs, chemical rinsing and precautions for penetrating or high-speed injury.

Explains urgent versus emergency symptoms and routes into assessment; local urgent-care numbers differ outside the UK.

Accessible overview of symptoms, investigation and treatment. Emergency numbers and referral routes should be adapted to the reader’s country.

General recovery and warning-sign information. A complex lens repair needs its own instructions from the treating service.

Detailed explanation of recovery, gas restrictions and symptoms requiring urgent postoperative contact.

Public explanation of one-eye versus two-eye symptoms and urgent warning signs.

Clear symptom, urgent-care and treatment explanation without requiring an account.

Explains testing, confidential partner support and links to sexual-health clinics. Routine clinic finding is not a substitute for urgent ophthalmic care.

Accessible multidisciplinary care explanation, including eye/orthoptic, rehabilitation and swallowing services.

Everyday recognition strategies and routes for discussing face-recognition difficulty.

Official eligibility information for sight tests and vouchers. Not a universal offer of free spectacles.

General recovery and retinal warning signs. Instructions for a complicated operation or vitrectomy should come from the treating team.

Symptoms and treatment overview with UK-specific urgent-contact guidance; use the equivalent local eye-care pathway elsewhere.

Patient and clinician information about same-side field loss, causes, function and assessment. This is not a peer-support community.

Find-a-neuro-ophthalmologist directory for symptoms involving vision and the nervous system. A professional directory is not a charity, emergency service or guarantee of appointment availability; ask about referral requirements and coverage.

Accessible explanation of pupil differences and associated warning signs.

Accessible pupil-difference explanation and downloadable patient information.

Search neuro-ophthalmology professionals. Listing does not guarantee an appointment, insurance coverage or emergency access.

Explains the same-side-in-both-eyes principle; broader half-field context is distinguished from quadrant loss.

Accessible explanation of pupil signs and why associated symptoms matter.

Patient explanation of the diagnostic process, eye findings and follow-up; printable material available.

Patient explanation and follow-up questions; its reassuring distinction from brain stroke should be read alongside newer vascular-risk research.

Explains diagnosis, visual changes and treatment uncertainty, with a linked medication-specific information update.

Concise explanation of neuromuscular weakness and symptoms for discussion with a clinical team.

Patient explanation, printable material and links to pediatric and ophthalmology information.

Patient explanations, printable material and links to further clinical information. It does not provide an individual diagnosis. This is a NANOS-listed external peer group; login may be required, and its activity and moderation were not independently verified.

Find neuro-ophthalmology professionals for optic-nerve assessment. A listing does not promise availability, insurance coverage or an urgent appointment.

Patient explanation of visual pathway compression and multidisciplinary care; the dated brochure is not individualized advice.

Useful when droop accompanies a pupil difference; it does not establish the diagnosis from appearance.

Explains a specific possible cause and the role of neuro-ophthalmic assessment; it is not a diagnosis for every new palsy.

Explains why prompt assessment matters and which details of an episode help the clinician.

Information, education support and separate online connection routes for acquired nystagmus, adults with congenital nystagmus and families. Peer experience is not medical advice.

Acquired-nystagmus information and online connection may be relevant to persistent visual instability; this is broader support, not a verified SOM-specific group. Peer experience is not medical advice.

Relevant when inflammation is the cause: educational material and peer meetings, not a diagnosis or replacement for treatment.

Free ocular-inflammatory-disease self-help groups, including adult, parent and teen routes, plus virtual meetings. Broader than neuroretinitis; support is not diagnosis or personalized drug advice. Private group content was not inspected.

Broader ocular-inflammatory-disease self-help support, including patient and family routes. This is not an orbital-diagnosis service; no private group content or individual treatment advice was accessed.

Official support hub lists virtual meetings and adult, parent and teen Facebook routes. Group admission is moderated; these are coping/connection resources, not personal medical treatment. The linked hub also contains older Q&A, so current clinical decisions belong with the treating team.

Official support directory explicitly includes scleritis. Peer discussion is not medical advice; private social groups require their own admission. Older clinical Q&A on the same site is not a current prescribing guide.

Adult, parent and teen self-help connections, education and virtual meetings. Peer discussion is non-medical; archived question-and-answer material is not an individualized treatment plan.

Detailed clinical consensus for discussion with a specialist, including long-term follow-up; not a home treatment protocol.

Explains ONH/hypopituitarism and endocrine follow-up; a Spanish PDF is linked. Terminology emphasizes the endocrine-associated spectrum.

Topic-specific research with the study-design limits described in this guide.

Multidisciplinary assessment examples across related developmental eye conditions.

Original research or specialist synthesis with limitations summarized below.

Specialist visual phenomenology and electrophysiologic context.

Original rare clinical example, not a diagnostic image or treatment prescription.

Current specialist discussion of differential diagnosis and limited treatment evidence.

Explains prevention evidence and its limits; not an instruction to exchange an existing implant.

Read the systematic-review abstract for the limits of current noninfectious retinal-vasculitis treatment evidence. It is not a trial recruitment portal or advice to change medicines.

Specialist overview of the diagnostic triad and ophthalmic role.

Topic-specific research with the study-design limits described in this guide.

Detailed phenomenology and case-report evidence limitations.

Detailed professional guidance and evidence references to discuss with a clinician.

Detailed evidence discussion across the major ocular complications and low-vision care.

Open clinical examples with case-series limitations; not a home diagnostic guide.

Original research or specialist synthesis with limitations summarized below.

Detailed assessment framework and referral discussion to bring to a professional conversation, rather than a home diagnostic checklist.

Review of the limited trial evidence for acute internal hordeolum; not a treatment helpline.

Detailed visual and ocular-motor associations and limitations.

Clinical spectrum, staging and treatment limitations.

Detailed specialist discussion of structures, complications and evidence gaps.

Evidence and uncertainties in post-stroke assessment and rehabilitation.

Condition-specific clinical background, testing and care context.

Respectful specialist explanation of diagnosis and management principles.

Technical definitions and examination context, not a self-diagnostic checklist.

Original clinical research, with referral-cohort limits.

Detailed investigation and management framework from pediatric specialist services; more technical than a patient leaflet.

Specific review of visual processing and functional consequences.

Diagnostic and management framework with medication-safety and evidence limitations.

Current specialist definitions and explicit treatment-evidence limitations.

Detailed clinical review for discussing tests and treatment categories with a corneal specialist; includes clinical photographs, which may be uncomfortable to view.

Detailed genetic/acquired retinal signaling context rather than a home night-vision test.

Clinical discussion of sheath inflammation and differential diagnosis; not a prescription or proof that every case follows the same course.

Open differential and management framework with condition-specific limitations.

Detailed clinical assessment and treatment-goal discussion.

Detailed clinical definition and differential context, not a self-diagnostic checklist.

Detailed specialist review of clinical distinctions and mechanisms.

Reference for clinicians; not a home-treatment algorithm and not a substitute for emergency services.

Original targeted convergence trial; does not establish universal vision-therapy benefit.

Open specialist discussion of diagnosis, care and evidence limitations.

Clinical background on presentations, causes and limitations.

Explains how front- and back-of-eye teams assess location, material and complications. Technical procedural content is for clinicians, not a home-care protocol.

Longer-term clinical trial follow-up with visual and developmental outcome limitations.

Professional evidence framework for esotropia and exotropia.

Specialist consensus on diagnostic context and overlap with other vestibular disorders; it does not provide a personal diagnosis or treatment plan.

Original experimental case, not a home task or general treatment recommendation.

Current multidisciplinary assessment and intervention framework with evidence limitations.

Detailed comparative-evidence limits, not a home treatment protocol.

Broader inherited-retinal peer support, webinars and an organization-verified community directory. Not an achromatopsia-only group; check each service’s availability and external privacy terms. Peer experience is not medical advice.

Inherited retinal condition information, helpline routes, wellbeing resources and local/online peer support.

Inherited-retinal-condition information, helpline and peer-support routes, including family-oriented practical support.

Inherited-retinal support and peer connection when an inherited cause has been established.

Official directory for inherited-retinal-disease information, webinars and non-medical peer connection; not a Sorsby-only group.

Organization-linked non-medical peer group, webinars and inherited-retinal information; no need to share a genetic report publicly.

Official inherited-retinal information, webinars and non-medical peer group. This is a broader community, not an XLRS-specific prescribing service.

Practical and emotional support, accessible technology, employment guidance and regional Connect communities. Peer discussions complement clinical care and are not medical advice.

Accessible CBS information and downloadable formats, with practical and emotional sight-loss support. General sight-loss support remains useful even when symptoms do not fit a single cause.

Broader peer connection for people affected by persistent sight difficulties and their families; not a condition-specific group or medical advice. Check each service’s geographic eligibility.

Broader sight-loss information and practical support routes when central-vision difficulties affect daily tasks; not an AVL-specific treatment service.

Information on stroke-related visual problems and support routes, relevant when stroke is the underlying cause.

Vision and support information relevant when stroke is the cause.

Practical sight-loss support and accessible-technology routes for persistent visual difficulties; not a Behçet treatment clinic.

Broader accessible-technology and daily-living support when contrast or visual-field problems affect tasks.

Practical support for persistent visual disability. This is a broader sight-loss route, not a fistula-specific treatment or emergency service.

Practical and emotional support for residual visual difficulty. Broader than this anatomical syndrome; a confirmed cause may lead to a more specific support organization.

Practical and emotional support for persisting visual disability after acute treatment. Not an infection-specific group or emergency service.

Task-based sight-loss and accessible-technology support when central vision remains difficult.

Practical and emotional sight-loss support if visual limitations persist; not specific treatment for a choroidal detachment.

Broader practical and emotional support for persistent vision or daily-living difficulties after diagnosis or treatment.

Explanations of visual effects, rehabilitation and support relevant to stroke.

Accessible information and routes to practical sight-loss support, including help adapting daily tasks.

Practical support if vision remains affected after infection, including accessible technology and community connections. This is not an emergency or infection-treatment service.

Condition-specific factsheet and sight-loss advice, including practical support when reading or detail vision is affected.

Accessible technology, rehabilitation information and community routes for persistent visual loss after an injury. This is not an emergency assessment service.

Field and other stroke-vision support information.

Practical help if vision is affected. It does not assess toxicity or make medication decisions.

Practical accessibility and community support if retinal or optic-nerve injury leaves visual difficulty. It is not a blood-pressure or emergency treatment service.

Access technology, practical support and non-medical peer connections for persistent visual difficulty.

Sight-loss technology, emotional support and community connection. Broader than a particular medicine reaction; peer support is not prescribing advice.

Practical and emotional support for lasting sight loss, including technology and community connection. This is follow-up support, not an acute poison service.

Technology, work and daily-living information plus non-medical peer connections.

Practical and emotional support, accessible technology and advice about living with sight loss. Check eligibility for specific UK services. Broader sight-loss community routes, not NAION-specific medical advice.

Practical sight-loss support and routes to community connection. Broader support for residual disability, not a sexual-health clinic or infection-specific treatment service.

Broader sight-loss rehabilitation and emotional/community support; no OPN-specific medical group is implied.

Sight-loss support for persistent functional needs. This is broader than orbital apex syndrome and cannot provide emergency orbital assessment.

Relevant only if sight difficulty persists: accessible technology, practical support and non-medical peer connections. No dedicated orbital-cellulitis charity is claimed.

Practical access, technology and emotional-support routes for persistent visual impairment, regardless of the pressure cause. Broader sight-loss support, not an emergency service or papilledema-specific community.

Practical information about light comfort and visual access. Its official moderated community directory is broader sight-loss support, not a photophobia-specific group.

Accessible PCO information and broader UK sight-difficulty peer routes for persistent functional needs. Laser risks should be discussed with the treating team; peer experiences are not individual predictions.

Broader vision support, accessible technology and community connections; no PION-specific charity or active dedicated group was verified.

Practical sight-loss support and non-medical peer groups for people with persistent difficulties or recovery concerns.

Access technology, work and daily-living support for ongoing sight difficulties.

Broader practical and emotional support for persistent visual disability. Not a THS-specific group or emergency service.

Practical and emotional support for sight loss, accessible technology and broader community connections. Not a dedicated traumatic optic neuropathy group.

Accessible explanation of uveitis, complications and support for sight-related tasks.

Explains field loss, neglect and practical support distinctions.

Practical sight-loss advice and non-medical community connections during persistent impairment or recovery. This does not replace urgent retinal assessment.

Information on diagnosis, communication, mobility, childhood and living with Usher. Its former dedicated Usher service transferred to Deafblind UK, so current referral arrangements should be checked.

Support for complex and multisensory disabilities, accessible communication, education and family or carer needs. Check eligibility and local service coverage.

Disease information, support and professional-network routes, mental-health resources and research-participation information.

Optic-neuritis education, current educational events, support-group routes and a resource library. Peer programs support connection and do not replace medical advice. Peer Connect supports adults and parents/guardians; volunteers do not provide medical or emergency advice.

Details current work on river blindness, other neglected infections and disability inclusion. Useful for understanding local partner roles, not self-prescribing.

Supports trachoma elimination, eye-care capacity and disability inclusion through local partners. Not a worldwide individual appointment or emergency service.

Condition-specific information to discuss with the treating team.

Definitions distinguishing size/distance distortions, afterimages, hallucinations and other phenomena.

Definitions including Anton syndrome and related visual-perception phenomena.

Anatomical and clinical teaching about vascular lesions. Images and examples are educational, not a diagnostic matching exercise.

Useful distinctions between visual loss, residual phenomena and awareness.

Detailed explanation of the classic localization pattern; based partly on older textbook material, not personal diagnostic advice.

Detailed anatomy and differential diagnosis. Some text comes from a 2012 textbook; it is not personal advice or a current treatment guideline.

Technical explanation of eye-movement initiation and related examination concepts.

Educational explanation within a broader eye-movement chapter; not an individualized diagnosis or referral guarantee.

Detailed pathway explanation; its position-test discussion should be read alongside the later acute-study limitations summarized here.

Definitions separating allesthesia, persistence, duplication and related visual experiences.

Public information about a staff-moderated stroke community for survivors and carers. Broader than carotid dissection; accounts and private participation are optional external services, not accessed here.

Stroke education and recovery support for survivors and caregivers. Groups in the registry may be independently run; confirm schedules and eligibility. Not all dissections cause a stroke.

Broader stroke support for people and families affected by stroke; not a dedicated OIS group. Registered groups may be independent; confirm meetings and eligibility.

Stroke education and adjustment support for people and families affected by stroke. Groups are broader than retinal arterial disease; check local eligibility and schedules.

Useful after a clinician identifies a vascular episode or stroke-related support need. This is not a diagnosis service for every transient visual symptom.

For people with an established brain-tumour diagnosis and families, not everyone with a gaze problem. Official directory separates patient, carer, parent and young-adult communities; experiences are not medical advice.

General brain-tumor peer groups and support information, including people with non-malignant tumors. Not ONSM-specific advice; check group eligibility.

Broader pediatric and family brain-tumor support, useful for sporadic as well as syndromic disease. Peer discussion is not medical advice.

Migraine education and support, relevant when migraine is an identified contributor rather than for every perceptual symptom.

Pituitary information, nurse/general support, telephone buddies and local or online groups. Peer support does not replace specialist endocrine or eye care.

Mitochondrial-disease education, support and a calendar including virtual meetings. These cover multiple mitochondrial diagnoses; a listed treatment or trial is not automatically relevant to this condition.

Mitochondrial disease education, support ambassadors, specialist discovery and research participation information. This lay organization does not provide medical advice.

MELAS-specific education, support-team routes and information about meetings and research.

Clearly distinguishes the basic eye-movement pattern from added facial-nerve involvement; illustrated cases are not diagnostic matching tools.

Detailed educational case and discussion. A case example does not establish the cause or treatment for another person.

Public information on voluntary suspected adverse-event reporting for patients and professionals; not an emergency service or individualized treatment advice.

Facilitated virtual groups, parent, young-adult and care-partner routes, plus affiliated community groups. Registration and space limits apply. Peer support does not replace urgent eye or rheumatology advice.

Useful when an associated vasculitis has been diagnosed. Facilitated meetings and affiliated community groups; this does not imply that every case of scleritis is vasculitis.

Ophthalmologist-authored explanation of affected eye structures, examination and the need to report visual changes. An undated educational page, not a substitute for current prescribing guidance.

Explains how systemic vasculitis can affect different eye structures. Its support directory is a broader route for people with relevant systemic disease, not proof that all retinal vasculitis is systemic.

Searchable support-group connections for vestibular conditions; group participation is separate from clinical care.

Visual snow education and care navigation that may be useful when a clinician finds palinopsia within VSS. It does not cover every neurologic, ocular or medication-related cause of recurrent images.

Resources about quality affordable refractive services. WHO does not directly provide an individual prescription or spectacles.

Current disease explanation and SAFE strategy. Elimination as a public-health problem does not mean every person with old scars no longer needs care.

Explains the ocular spectrum and the limits of interpreting serum retinol; historical burden figures on this page are not presented as current global counts.